The World Health Organization (WHO) estimated that at least 1 million children became ill and 210,000 children died of TB in 2015. Our children deserve better. #TBKids

Only 20% of the 580K people who developed MDR-TB in 2015 were treated. We cannot allow so many voices to be silenced. #LouderthanTB

Use of short course regimens leads to significantly increased proportions of DR-TB patients culture converted @ 2mo #unionconf Jay Achar

80% RR-TB pts had a successful clinical & microbiological outcome at 6mo followup after the end of tx #unionconf #nixtb #endtb TB Alliance

33 RR-TB patients have completed 6mos of the NixTB trial (LZD+BDQ+Pa 6-9mo regimen), all culture converted by 4mos #unionconf TB Alliance

DR-TB patients treated with BDQ containing regimens have significantly decreased time to culture conversion @animesh4767 @msf_tb #unionconf

.MSF International supported 20,000 #TB patients in 2015. Here are some of them: msf.org/en/article/gal…

#thebittertruth x.com/Karabo_Mokgoko…

Multidrug-resistant TB rates soaring in west Africa, WHO warns theguardian.com/society/2016/n…

youtube.com/watch?v=a7Cy95… Blown away by the bravery and strength of this woman battling XDR-TB and HIV. #advocacy #stopTB #reducestigma

gatesnotes.com/Health/Lets-Ma… @msf_tb expanding access to new DR-TB drugs is essential in order to improve DR-TB tx outcomes #endTB #stoptb #msf

journals.plos.org/plosone/articl… Hard work invested into this study to further advocate for decentralized DR-TB TX in SA & globally #decentralizeTBtx

#RCAConf Healthcare is a priority. The challenges: safe access to healthcare, sufficient funding and improved policies #CARcrisis

As per a briefing paper published by MSF International ,India has the largest burden of #TB in the world with more than a quarter of the world’s patients

msf.exposure.co/delamanid-in-s… Not only do our patients humble me, this woman humbles me, what a dedicated doctor @msf_tb #endTB #stopTB #MSF

huffingtonpost.co.za/doctors-withou… @msf_tb we need better DR-TB drugs and improved regimens for our patients urgently #stopTB #DRTB #endTB #MSF

#Wishlist2017: MSF International’s #tuberculosis doctor Animesh in Belarus wishes more patients could access lifesaving new TB drugs

nytimes.com/2017/01/30/hea… we need to get to the root of the problem and put an end to community transmission of XDR @msf_tb #endTB #MSF

Operational research over the rooftops of #Addis: Erika Mohr is working on assessing the treatment of rifampicin-resistant #tuberculosis with delamanid in Khayelitsha, South Africa – a township with very high tuberculosis and #HIV co-infection burden.

What does it take to treat #hypertension in a low-income context like #Kibera, #Kenya? Placing service clinics in strategic locations, offering services for men outside working hours, and using simpler medication, Martha Ng’endo Kuria’s OR-study shows.